JP2022529485A5 - - Google Patents
Info
- Publication number
- JP2022529485A5 JP2022529485A5 JP2021562097A JP2021562097A JP2022529485A5 JP 2022529485 A5 JP2022529485 A5 JP 2022529485A5 JP 2021562097 A JP2021562097 A JP 2021562097A JP 2021562097 A JP2021562097 A JP 2021562097A JP 2022529485 A5 JP2022529485 A5 JP 2022529485A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024205936A JP2025028979A (ja) | 2019-04-23 | 2024-11-27 | 真核細胞用の細胞培地 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962837263P | 2019-04-23 | 2019-04-23 | |
| US62/837,263 | 2019-04-23 | ||
| PCT/US2020/029370 WO2020219582A1 (en) | 2019-04-23 | 2020-04-22 | Cell culture medium for eukaryotic cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024205936A Division JP2025028979A (ja) | 2019-04-23 | 2024-11-27 | 真核細胞用の細胞培地 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022529485A JP2022529485A (ja) | 2022-06-22 |
| JP2022529485A5 true JP2022529485A5 (https=) | 2023-04-21 |
| JPWO2020219582A5 JPWO2020219582A5 (https=) | 2023-04-21 |
Family
ID=70681881
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021562097A Pending JP2022529485A (ja) | 2019-04-23 | 2020-04-22 | 真核細胞用の細胞培地 |
| JP2024205936A Pending JP2025028979A (ja) | 2019-04-23 | 2024-11-27 | 真核細胞用の細胞培地 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024205936A Pending JP2025028979A (ja) | 2019-04-23 | 2024-11-27 | 真核細胞用の細胞培地 |
Country Status (15)
| Country | Link |
|---|---|
| US (5) | US10961500B1 (https=) |
| EP (1) | EP3959234A1 (https=) |
| JP (2) | JP2022529485A (https=) |
| KR (1) | KR20220003563A (https=) |
| CN (1) | CN113710696A (https=) |
| AU (1) | AU2020262117B2 (https=) |
| BR (1) | BR112021020501A2 (https=) |
| CA (1) | CA3136827A1 (https=) |
| EA (1) | EA202192893A1 (https=) |
| IL (1) | IL287387A (https=) |
| MX (1) | MX2021012649A (https=) |
| MY (1) | MY198223A (https=) |
| SG (1) | SG11202111252QA (https=) |
| WO (1) | WO2020219582A1 (https=) |
| ZA (1) | ZA202107808B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10961500B1 (en) * | 2019-04-23 | 2021-03-30 | Regeneron Pharmaceuticals, Inc. | Cell culture medium for eukaryotic cells |
| WO2023278525A1 (en) * | 2021-06-29 | 2023-01-05 | Biomarin Pharmaceutical Inc. | Cell culture feed for recombinant adeno-associated virus production in mammalian cells |
| CN118240749B (zh) * | 2024-05-28 | 2024-08-06 | 烟台赛普生物技术有限公司 | 一种灌流培养基及其制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1312030C (en) * | 1987-11-18 | 1992-12-29 | Brian Maiorella | Method to increase antibody titer |
| EP1482031B1 (en) * | 1996-08-30 | 2015-10-28 | Life Technologies Corporation | Serum-free mammalian cell culture medium, and uses thereof |
| US6406909B1 (en) * | 1998-07-10 | 2002-06-18 | Chugai Seiyaku Kabushiki Kaisha | Serum-free medium for culturing animal cells |
| AT409379B (de) * | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
| US7087411B2 (en) * | 1999-06-08 | 2006-08-08 | Regeneron Pharmaceuticals, Inc. | Fusion protein capable of binding VEGF |
| US20030096414A1 (en) * | 2001-03-27 | 2003-05-22 | Invitrogen Corporation | Culture medium for cell growth and transfection |
| SG106672A1 (en) | 2002-03-08 | 2004-10-29 | Asml Netherlands Bv | Mask for use in lithography, method of making a mask, lithographic apparatus, and device manufacturing method |
| ATE541919T1 (de) * | 2005-02-11 | 2012-02-15 | Novo Nordisk Healthcare Ag | Herstellung eines proteins in serumfreier zellkultur, die ein proteinhydrolysat aus pflanzen enthält |
| WO2008154014A2 (en) * | 2007-06-11 | 2008-12-18 | Amgen Inc. | A method for culturing mammalian cells to improve recombinant protein production |
| BRPI0919034A8 (pt) * | 2008-09-26 | 2016-02-10 | Schering Corp | Métodos para produzir uma proteína e um anticorpo, meio líquido aquoso para cultura, e, vaso |
| CN104059955A (zh) | 2009-08-11 | 2014-09-24 | 弗·哈夫曼-拉罗切有限公司 | 在无谷氨酰胺的细胞培养基中的蛋白质生产 |
| CA2805557A1 (en) * | 2010-07-08 | 2012-01-12 | Baxter International Inc. | Method of producing recombinant high molecular weight vwf in cell culture |
| US9677105B2 (en) * | 2013-03-14 | 2017-06-13 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| AR095196A1 (es) * | 2013-03-15 | 2015-09-30 | Regeneron Pharma | Medio de cultivo celular libre de suero |
| TW202440904A (zh) | 2015-08-04 | 2024-10-16 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法（二） |
| KR102659791B1 (ko) * | 2017-07-06 | 2024-04-23 | 리제너론 파마슈티칼스 인코포레이티드 | 당단백질을 만들기 위한 세포 배양 과정 |
| US10961500B1 (en) * | 2019-04-23 | 2021-03-30 | Regeneron Pharmaceuticals, Inc. | Cell culture medium for eukaryotic cells |
-
2020
- 2020-01-27 US US16/752,874 patent/US10961500B1/en active Active
- 2020-04-22 MY MYPI2021006125A patent/MY198223A/en unknown
- 2020-04-22 KR KR1020217037669A patent/KR20220003563A/ko active Pending
- 2020-04-22 CN CN202080030558.8A patent/CN113710696A/zh active Pending
- 2020-04-22 BR BR112021020501A patent/BR112021020501A2/pt unknown
- 2020-04-22 MX MX2021012649A patent/MX2021012649A/es unknown
- 2020-04-22 WO PCT/US2020/029370 patent/WO2020219582A1/en not_active Ceased
- 2020-04-22 EP EP20725601.7A patent/EP3959234A1/en active Pending
- 2020-04-22 JP JP2021562097A patent/JP2022529485A/ja active Pending
- 2020-04-22 EA EA202192893A patent/EA202192893A1/ru unknown
- 2020-04-22 CA CA3136827A patent/CA3136827A1/en active Pending
- 2020-04-22 SG SG11202111252QA patent/SG11202111252QA/en unknown
- 2020-04-22 AU AU2020262117A patent/AU2020262117B2/en active Active
-
2021
- 2021-03-24 US US17/211,596 patent/US11286460B2/en active Active
- 2021-10-14 ZA ZA2021/07808A patent/ZA202107808B/en unknown
- 2021-10-19 IL IL287387A patent/IL287387A/en unknown
-
2022
- 2022-02-22 US US17/677,163 patent/US11555176B2/en active Active
- 2022-12-13 US US18/080,373 patent/US11821001B2/en active Active
-
2023
- 2023-11-20 US US18/514,880 patent/US20240084248A1/en active Pending
-
2024
- 2024-11-27 JP JP2024205936A patent/JP2025028979A/ja active Pending